81444-75-9

Basic information

• Product Name: N-(benzyloxycarbonyl)-L-tryptophanyl-D-tryptophan methyl ester
• Synonyms: N-(benzyloxycarbonyl)-L-tryptophanyl-D-tryptophan methyl ester
• CAS NO: 81444-75-9
• Molecular Weight: 538.603
• Mol File: 81444-75-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: N-(benzyloxycarbonyl)-L-tryptophanyl-D-tryptophan methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N-(benzyloxycarbonyl)-L-tryptophanyl-D-tryptophan methyl ester(81444-75-9)
• EPA Substance Registry System: N-(benzyloxycarbonyl)-L-tryptophanyl-D-tryptophan methyl ester(81444-75-9)

Safety Data

• Hazardous Substances Data: 81444-75-9(Hazardous Substances Data)

Upstream product

• 4299-70-1 D-Tryptophan methyl ester 
• 7432-21-5 N-carbobenzyloxy-L-tryptophane 
• 14907-27-8 (R)-(+)-tryptophan methyl ester hydrochloride 

Downstream Products

• 82989-15-9 Z-(L)-Trp-(D)-Trp-(L)-Pro-PNP 
• 82989-11-5 Z-(L)-Trp-(D)-Trp(COOH) 

Relevant articles and documents

TREATMENT OF PROTEIN FOLDING DISORDERS

In certain embodiments, the invention is directed to a method for treating a protein folding disorder such as Alzheimer's disease, dementia, Parkinson's disease, Huntington's disease and prion-based spongiform encephalopathy. The method comprises the administration to a subject of a compound of the formula (I) wherein A and B are independently a mono- or bicyclic aromatic group or heteroaromatic cyclic group. In preferred embodiments, the compounds are bis-indole compounds.

Ground- and Excited-State Conformational Differences between Diastereomeric Dipeptides

Ground- and excited-state conformations of D-tryptophanyl-L-tryptophan methyl ester (1DL) L-tryptophanyl-L-tryptophan methyl ester (1LL) have been investigated by 1H NMR and by steady-state and subnanosecond time-resolved fluorescenc